| Biliary Disease |
1 |
1 |
| Gallbladder |
0 |
0.99 |
| Obesity |
0 |
0.98 |
| Gallbladder Cancer |
0 |
0.52 |
| Weight Loss |
0 |
0.48 |
| Weight Management |
0 |
0.97 |
| Type 2 Diabetes Mellitus |
0 |
0.43 |
| Meta-Analysis |
0 |
0.21 |
| GLP-1 Receptor Agonist |
0 |
0.18 |
| Gallstone |
0 |
0.16 |
| Cancer |
0 |
0.11 |
| Cholecystectomy |
0 |
0.11 |
| Cholecystitis |
0 |
0.11 |
| Receptors |
0 |
0.11 |
| Polycystic Ovary Syndrome |
0 |
0.07 |
| Biliary Obstruction |
0 |
0.05 |
| Body Mass Index |
0 |
0.05 |
| Cardiovascular Risk Management |
0 |
0.05 |
| Electronic Health Record (EHR) |
0 |
0.05 |
| Food and Drug Administration (FDA) |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Infertility Female |
0 |
0.05 |
| Medical Innovations |
0 |
0.05 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.05 |
| Nonalcoholic Steatohepatitis |
0 |
0.05 |
| Ovary |
0 |
0.05 |
| Schizophrenia |
0 |
0.05 |